EUVIMEDOpdag EUVIMED
BeobachtungsstudieOpen access · CC BY-NC 4.0

Intercountry comparisons of advanced Parkinson's disease symptoms and management: Analysis from the OBSERVE‐PD observational study

Alfonso Fasano, Victor S C Fung, Klaus Seppi, Zvezdan Pirtosek, Annamária Takáts, Ali Alobaidi, Koray Onuk, Lars Bergmann, Juan Carlos Parra, Bulent Elibol

Acta Neurologica Scandinavica · 2022-08 · 146 (2) · 167-176

DOI: 10.1111/ane.13648 ↗

At a glance

Beobachtungsstudie in Acta Neurologica Scandinavica, published online on 2022-05-24. Written by Alfonso Fasano and 9 co-authors. Institution: Edmond J Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, ON, Canad…. Major MEDLINE topics: Parkinson Disease. Cited 13 times so far (Crossref); 22 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: AbbVie.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

OBJECTIVES: In the absence of widely accepted criteria, determining when a patient with Parkinson's disease (PD) may benefit from more advanced treatments such as device-aided therapy (DAT) so far remains a matter of physician judgment. This analysis investigates how classification of PD varies across countries relative to measures of disease severity. MATERIALS AND METHODS: The OBSERVational, cross-sEctional PD (OBSERVE-PD) study included consecutive patients with PD at centers that offer DATs in 18 countries. In this subgroup analysis, we explore intercountry differences in identification of advanced versus non-advanced PD based on physician's clinical judgment, symptoms assessed using Delphi consensus criteria, use of DAT, motor and non-motor symptoms, and caregiver support. Demographic and clinical characteristics were obtained through review of medical records. RESULTS: Overall, 1342 of 2615 patients (51.3%) were assessed by physicians as having advanced PD. The proportion of patients in different countries identified as having advanced PD (24.4-82.2%) varied. In 15 of 18 countries, a greater proportion of patients with advanced PD, according to select Delphi criteria, were identified by physicians as having advanced PD than with non-advanced PD. There was a wide variability across countries in the proportion of patients with no dyskinesia, disabling dyskinesia, dyskinesia pain, and non-motor symptoms who were identified by physicians as having advanced versus non-advanced PD. CONCLUSIONS: The proportion of patients identified with advanced PD symptoms varies widely across countries, despite differences on the patients' profiles, indicating a need for objective diagnostic criteria to help identify patients who may benefit from DAT.

Subjects

MeSH terms (MEDLINE)

Parkinson DiseaseAntiparkinson AgentsCarbidopaCross-Sectional StudiesDrug CombinationsGelsHumansLevodopaSeverity of Illness Index

Author keywords

Delphi studyParkinson's diseaseapomorphinedeep-brain stimulationinfusion pumpintraintestinal infusionlevodopa-carbidopa drug combination

Substances

Antiparkinson AgentsDrug CombinationsGelsLevodopaCarbidopa

Authors and institutions

  • Edmond J Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, ON, Canada.
  • Division of Neurology, University of Toronto, Toronto, ON, Canada.
  • Krembil Research Institute, Toronto, ON, Canada.
  • Movement Disorders Unit, Westmead Hospital, Westmead, NSW, Australia.
  • Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
  • Medical University Innsbruck, Innsbruck, Austria.

Funding

  • AbbVie

Cite

APA

Fasano, A., Fung, V. S. C., Seppi, K., Pirtosek, Z., Takáts, A., Alobaidi, A., Onuk, K., Bergmann, L., Parra, J. C., & Elibol, B. (2022). Intercountry comparisons of advanced Parkinson's disease symptoms and management: Analysis from the OBSERVE‐PD observational study. Acta Neurologica Scandinavica, 146(2), 167-176. https://doi.org/10.1111/ane.13648

Vancouver

Fasano A, Fung VSC, Seppi K, Pirtosek Z, Takáts A, Alobaidi A, et al. Intercountry comparisons of advanced Parkinson's disease symptoms and management: Analysis from the OBSERVE‐PD observational study. Acta Neurologica Scandinavica. 2022;146(2):167-176. doi:10.1111/ane.13648

BibTeX
@article{Fasano2022,
  author = {Fasano, Alfonso and Fung, Victor S C and Seppi, Klaus and Pirtosek, Zvezdan and Takáts, Annamária and Alobaidi, Ali and Onuk, Koray and Bergmann, Lars and Parra, Juan Carlos and Elibol, Bulent},
  title = {Intercountry comparisons of advanced Parkinson's disease symptoms and management: Analysis from the OBSERVE‐PD observational study},
  journal = {Acta Neurologica Scandinavica},
  year = {2022},
  volume = {146},
  number = {2},
  pages = {167--176},
  doi = {10.1111/ane.13648}
}
Start for free →